SPO Medical Inc - FORM 10-K - XML - IDEA: XBRL DOCUMENT - April 5, 2012

Attached files
FileFilename
XML - IDEA: XBRL DOCUMENT - SPO Medical IncR20.htm
XML - IDEA: XBRL DOCUMENT - SPO Medical IncR10.htm
XML - IDEA: XBRL DOCUMENT - SPO Medical IncR5.htm
XML - IDEA: XBRL DOCUMENT - SPO Medical IncR21.htm
XML - IDEA: XBRL DOCUMENT - SPO Medical IncR16.htm
XML - IDEA: XBRL DOCUMENT - SPO Medical IncR14.htm
XML - IDEA: XBRL DOCUMENT - SPO Medical IncR13.htm
XML - IDEA: XBRL DOCUMENT - SPO Medical IncR15.htm
XML - IDEA: XBRL DOCUMENT - SPO Medical IncR19.htm
XML - IDEA: XBRL DOCUMENT - SPO Medical IncR11.htm
XML - IDEA: XBRL DOCUMENT - SPO Medical IncR12.htm
XML - IDEA: XBRL DOCUMENT - SPO Medical IncR18.htm
XML - IDEA: XBRL DOCUMENT - SPO Medical IncR1.htm
XML - IDEA: XBRL DOCUMENT - SPO Medical IncR17.htm
XML - IDEA: XBRL DOCUMENT - SPO Medical IncR3.htm
XML - IDEA: XBRL DOCUMENT - SPO Medical IncR7.htm
XML - IDEA: XBRL DOCUMENT - SPO Medical IncR22.htm
XML - IDEA: XBRL DOCUMENT - SPO Medical IncR6.htm
XML - IDEA: XBRL DOCUMENT - SPO Medical IncR2.htm
XML - IDEA: XBRL DOCUMENT - SPO Medical IncR8.htm
EXCEL - IDEA: XBRL DOCUMENT - SPO Medical IncFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - SPO Medical IncR9.htm
EX-32 - EXHIBIT 32 - SPO Medical Incv308484_ex32.htm
EX-31 - EXHIBIT 31 - SPO Medical Incv308484_ex31.htm
10-K - ANNUAL REPORT FORM 10-K - SPO Medical Incv308484_10k.htm
v2.4.0.6
CONSOLIDATED STATEMENT OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Revenues $ 20 $ 192
Cost of revenues 10 151
Gross profit 10 41
Operating expenses    
Research and development, net 57 302
Selling and marketing 1,142 975
General and administrative 522 703
Impairment of property and equipment, net 96  
Restructuring of debt   (64)
Total operating expenses 1,817 1,916
Operating loss (1,807) (1,875)
Financial income (expense), net 200 (299)
Net Loss for the year $ (1,607) $ (2,174)
Basic and diluted loss per share $ (0.05) $ (0.08) [1]
Weighted average number of shares outstanding used in computation of basic and diluted loss per share 33,570,581 28,369,367 [1]
[1] Restated to the correct amounts

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA


This web site and associated pages are not associated with, endorsed by, or sponsored by SPO Medical Inc and has no official or unofficial affiliation with SPO Medical Inc


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.